PHARMATROPHIX INC has a total of 50 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, China and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are GR NENTHAL GMBH, ACURE PHARMA AB and PANMIRA PHARMACEUTICALS LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | China | 7 | |
#3 | WIPO (World Intellectual Property Organization) | 7 | |
#4 | EPO (European Patent Office) | 6 | |
#5 | Hong Kong | 5 | |
#6 | Australia | 4 | |
#7 | Canada | 4 | |
#8 | Brazil | 2 | |
#9 | Japan | 2 | |
#10 | Republic of Korea | 2 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Acyclic or carbocyclic compounds | |
#4 | Heterocyclic compounds | |
#5 | Organic chemistry methods | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Longo Frank M | 34 |
#2 | Munigeti Rajgopal | 20 |
#3 | Ron Dorit | 3 |
#4 | Massa Stephen | 3 |
#5 | Longo Frank | 3 |
#6 | Frank M Longo | 2 |
#7 | Rajgopal Munigeti | 2 |
#8 | Longo Frank M Fm | 2 |
#9 | Munigeti Rajgopal R | 2 |
#10 | Monje Michelle | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020154434A1 | Compositions and methods for treating and preventing cognitive dysfunction | |
US2019231787A1 | Methods and compounds for treating alcohol use disorders and associated diseases | |
US2018037560A1 | Crystalline forms of neurotrophin mimetic compounds and their salts | |
US2014296343A1 | Non-peptide bdnf neurotrophin mimetics | |
WO2014143985A1 | Non-peptide bdnf neurotrophin mimetics | |
CN105209427A | Non-peptide BDNF neurotrophin mimics | |
AU2013323416A1 | Crystalline forms of neurotrophin mimetic compounds and their salts | |
HK1177152A1 | Crystalline forms of neurotrophin mimetic compounds and their salts | |
WO2011066544A2 | Deuterated compounds useful for treating neurodegenerative diseases | |
CN102740856A | Crystalline forms of neurotrophin mimetic compounds and their salts |